Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
Although genomic classifier tests for prostate cancer show promise, a systematic review of 22 studies reveals marked differences between observational and trial data in how these tests influence risk stratification and treatment selection.
Oncology, Medical February 3rd 2025
MDLinx
In a significant stride toward personalized medicine, researchers have utilized AI to unveil two distinct evotypes of prostate cancer, heralding a new era in the disease’s diagnosis and management. This pivotal discovery opens doors to tailored treatment strategies, potentially mitigating the adverse effects of over-treatment in prostate cancer.
Hematology/Oncology March 25th 2024
Roswell Park
Recent advancements in cancer research reveal the potential of using the immune system’s response to activated retrotransposons for early detection of cancers such as lung, pancreatic, and ovarian. This innovative approach could revolutionize cancer diagnostics.
Hematology/Oncology January 22nd 2024
Discover how a study from USC reveals that the most common genetic cause of ALS and FTD may have its roots in embryonic development, offering new avenues for early diagnosis and treatment.
Neurology August 30th 2023
Dana-Farber Cancer Institute
Explore the potential of OncoNPC, an AI model that leverages gene sequencing data to predict the primary source of cancer, offering a new avenue for more targeted and effective treatments.
Hematology/Oncology August 29th 2023
Cancer Therapy Advisor
Explore the complexities of treating small cell lung cancer (SCLC) after platinum-based therapy failure, including insights into immune checkpoint inhibitors, the preference for lurbinectedin, and the potential of liquid biopsies. Join Dr. Misty Shields in understanding the challenges and opportunities in this evolving field.
Oncology, Medical August 21st 2023